Exterran corporation (EXTN)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flows from operating activities:
Net loss

-115,287

-102,377

-8,467

6,743

14,123

24,854

17,443

15,427

18,896

33,880

444

-15,569

-114,659

-227,937

-205,246

-183,909

-102,786

26,648

0

0

0

Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization

156,950

162,557

148,270

137,245

131,110

123,922

122,035

117,937

114,101

107,824

104,463

105,636

106,705

132,886

142,700

150,600

159,236

146,318

0

0

0

Impairments

-

-

-

-

-

3,858

9,558

7,504

7,504

5,700

8,486

13,844

13,844

14,495

12,533

10,950

16,860

20,788

0

0

0

Amortization of deferred financing costs

2,512

2,512

3,217

3,261

3,305

3,347

2,684

2,681

4,253

4,714

5,175

5,638

4,635

4,584

4,155

3,023

1,782

702

0

0

0

(Income) loss from discontinued operations, net of tax

6,169

6,486

25,420

29,139

23,226

24,462

9,695

9,661

8,491

39,736

12,425

29,938

40,600

-56,171

-65,130

-66,507

-77,336

4,723

0

0

0

Provision for doubtful accounts

2,774

32

-572

-520

-129

86

138

516

592

863

2,254

2,531

2,695

2,972

3,815

3,694

3,913

3,326

0

0

0

Gain on sale of property, plant and equipment

2,348

3,187

1,645

1,413

1,402

629

1,467

1,620

2,710

2,517

2,027

1,930

2,919

2,986

2,999

3,078

1,781

1,805

0

0

0

Income (Loss) from Equity Method Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

10,403

10,403

15,487

15,320

15,152

0

0

0

Gain on remeasurement of intercompany balances

975

300

-802

-82

-4,124

-5,200

-6,218

-3,607

-1,592

500

1,851

1,780

6,152

9,300

15,345

-14,582

-18,009

-30,127

0

0

0

Loss on foreign currency derivatives

-129

-794

-794

-794

-665

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on sale of businesses

-

-

-

-

-

-

-

-

-

-111

-111

-111

-111

0

0

0

0

-

-

-

-

Stock-based compensation expense

9,039

12,750

14,093

14,992

14,959

14,567

13,930

13,261

13,065

14,764

12,470

12,271

11,876

10,966

12,987

11,684

10,562

8,184

0

0

0

Deferred income tax expense (benefit)

-7,666

-10,007

452

622

2,263

1,537

-5,193

522

-4,851

-3,193

-4,745

-8,809

79,969

71,090

65,930

47,156

-39,367

-25,838

0

0

0

Changes in assets and liabilities:
Accounts receivable and notes

-69,215

-50,730

-15,125

3,202

28,830

-8,669

-3,977

28,293

1,573

65,311

56,637

39,482

-2,951

-126,276

-121,108

-103,641

-82,658

-34,428

0

0

0

Inventory

-15,690

8,369

32,695

18,810

44,811

59,676

40,315

55,533

7,558

-20,594

-14,717

-18,995

-29,807

-49,736

-96,260

-114,773

-120,602

-80,416

0

0

0

Costs and estimated earnings versus billings on uncompleted contracts

-

-

-

-

-

-

-

-

-

-40,949

-62,546

-52,881

-63,939

-24,637

-14,771

-2,108

25,890

24,328

0

0

0

Contract assets

-14,408

-28,352

-30,982

-31,060

-14,071

34,571

16,263

21,582

31,397

0

0

0

0

-

-

-

-

-

-

-

-

Other current assets

-19,402

-20,312

-16,509

-3,441

2,366

-5,045

-7,475

-13,685

-4,478

1,541

17,487

23,671

9,428

7,074

-10,548

-14,309

-16,458

162

0

0

0

Accounts payable and other liabilities

-99,687

-41,092

-78,583

-39,594

15,091

13,801

50,629

78,303

61,586

62,029

68,327

61,787

15,843

2,078

-38,637

-58,468

-42,153

-82,595

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-13,711

2,113

-4,505

18,857

24,414

31,188

24,084

7,333

-2,428

0

0

0

Contract liabilities

-5,111

-8,263

98,943

99,803

93,414

62,934

-11,937

-3,746

-6,429

0

0

0

0

-

-

-

-

-

-

-

-

Other

-9,360

-3,854

5,237

4,397

-2,525

-3,059

2,905

12,485

12,825

14,483

15,401

4,409

1,848

857

-93

-14,102

1,707

4,806

0

0

0

Net cash provided by continuing operations

136,622

176,198

185,498

208,982

198,695

153,296

117,979

122,956

124,691

150,420

170,687

143,796

171,138

262,489

309,175

320,817

285,745

189,100

0

0

0

Net cash provided by (used in) discontinued operations

1,335

2,528

4,827

6,225

6,869

4,004

1,287

-3,411

-10,154

-1,794

1,363

6,677

4,340

1,016

-66,638

-65,641

-55,488

-57,404

0

0

0

Net cash provided by operating activities

137,957

178,726

190,325

215,207

205,564

157,300

119,266

119,545

114,537

148,626

172,050

150,473

175,478

263,505

242,537

255,176

230,257

131,696

0

0

0

Cash flows from investing activities:
Capital expenditures

133,945

193,274

235,000

246,990

242,243

215,108

204,777

181,691

160,302

131,673

105,103

87,099

79,809

73,670

80,936

104,672

129,272

155,344

0

0

0

Proceeds from sale of property, plant and equipment

15,814

19,662

4,382

4,307

4,282

2,530

4,741

4,811

8,542

8,866

8,397

8,342

5,313

2,814

2,306

2,422

3,094

6,609

0

0

0

Proceeds from Divestiture of Businesses

-

-

-

-

-

-

-

-

-

894

894

894

894

0

0

0

0

-

-

-

-

Proceeds from Sale of Equity Method Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

10,403

10,403

15,520

15,353

15,185

0

0

0

Settlement of foreign currency derivatives

587

794

794

794

207

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in continuing operations

-

-

-

-

-

-207,578

-195,036

-171,880

-151,760

-121,913

-96,533

-78,519

-69,082

-61,162

-68,214

-86,816

-105,501

-128,226

0

0

0

Cash Provided by (Used in) Investing Activities, Discontinued Operations

-

-

-

-

-

17,009

287

477

491

19,575

18,699

40,606

57,056

36,079

51,573

45,401

27,781

46,112

0

0

0

Net cash used in investing activities

-118,718

-174,406

-214,469

-226,534

-216,225

-190,569

-194,749

-171,403

-151,269

-102,338

-77,834

-37,913

-12,026

-25,083

-16,641

-41,415

-77,720

-82,114

0

0

0

Cash flows from financing activities:
Proceeds from borrowings of debt

575,500

642,500

700,014

716,014

697,514

585,014

428,088

268,088

507,088

501,088

565,000

634,500

333,758

430,758

1,027,258

957,758

831,000

673,500

0

0

0

Repayments of debt

555,451

603,951

624,464

658,964

651,047

550,497

377,934

235,384

432,003

476,503

565,253

661,753

450,761

610,261

652,448

555,885

396,063

143,500

0

0

0

Payment for Spin-off Transaction

-

-

-

-

-

-

-

-

-

44,720

44,720

64,234

63,743

49,176

581,754

562,240

537,731

532,578

0

0

0

Payments for debt issuance costs

-

-

-

-

-

4,801

92

352

7,958

7,911

0

0

0

-

-

-

-

-

-

-

-

Net contributions from parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from stock options exercised

-

-

-

-

-

548

548

563

428

684

776

776

776

786

694

694

694

0

0

0

0

Purchases of treasury stock (Note 10)

39,141

45,007

42,439

22,453

7,884

4,623

5,253

5,149

5,208

4,792

3,966

3,788

3,701

2,091

1,498

1,481

1,468

54

0

0

0

Net cash provided by financing activities

-18,672

-6,038

10,078

11,504

15,205

6,897

45,357

27,766

37,347

-32,154

-56,074

-102,105

-184,450

-230,763

-220,781

-197,913

-160,532

-56,195

0

0

0

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-1,169

-1,058

-1,448

-1,718

-3,672

-3,841

-4,110

-3,205

-1,418

-792

63

670

-792

-1,832

-5,008

-5,477

-4,470

-3,716

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

-602

-2,776

-15,514

-1,541

872

-30,213

-34,236

-27,297

-803

13,342

38,205

11,125

-21,790

5,827

107

10,371

-12,465

-10,329

0

0

0

Supplemental disclosure of non-cash transactions:
Accrued capital expenditures

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-